16S V3-V4 -based microbial profiling of matched healthy and inflamed ileal mucosa from patients affected by Crohn’s disease (set 2)
Download from source ↗Dataset overview
Crohn's disease recurrence updates: first surgery <i>vs</i>. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors.
Abstract
<h4>Background and aims</h4>Crohn's disease (CD) pathogenesis is still unclear. Remodeling in mucosal microbiota and systemic immunoregulation may represent an important component in tissue injury. Here, we aim to characterize the ileal microbiota in both pathological and healthy settings and to evaluate the correlated systemic microbial-associated inflammatory markers comparing first-time surgery and relapse clinical conditions.<h4>Methods</h4>We enrolled 28 CD patients at surgery; we collected inflamed and non-inflamed mucosa tissues and blood samples from each patient. Bacterial wall adherence was observed histologically, while its composition was assessed through amplicon sequencing of the 16S rRNA gene. In addition, we evaluated the systemic microRNA (miRNA) using quantitative real-time PCR amplification and free fatty acids (FFAs) using gas chromatography-mass spectroscopy.<h4>Results</h4>The total number of mucosal adherent microbiota was enriched in healthy compared to inflamed mucosa. In contrast, the phylum <i>Tenericutes</i>, the family <i>Ruminococcaceae</i>, and the genera <i>Mesoplasma</i> and <i>Mycoplasma</i> were significantly enriched in the pathological setting. Significant microbiota differences were observed between the relapse and first surgery patients regarding the families <i>Bacillaceae 2</i> and <i>Brucellaceae</i> and the genera <i>Escherichia/Shigella</i>, <i>Finegoldia</i>, <i>Antrobacter</i>, <i>Gemmatimonas</i>, <i>Moraxella</i>, <i>Anoxibacillus</i>, and <i>Proteus</i>. At the systemic level, we observed a significant downregulation of circulating miR-155 and miR-223, as well as 2-methyl butyric, isobutyric, and hexanoic (caproic) acids in recurrence compared to the first surgery patients. In addition, the level of hexanoic acid seems to act as a predictor of recurrence risk in CD patients (OR 18; 95% confidence interval 1.24-261.81; <i>p</i> = 0.006).<h4>Conclusions</h4>We describe a dissimilarity of ileal microbiota composition comparing CD and healthy settings, as well as systemic microbial-associated inflammatory factors between first surgery and surgical relapse. We suggest that patterns of microbiota, associated with healthy ileal tissue, could be involved in triggering CD recurrence. Our findings may provide insight into the dynamics of the gut microbiota-immunity axis in CD surgical recurrence, paving the way for new diagnostics and therapeutics aimed not only at reducing inflammation but also at maintaining a general state of eubiosis in healthy tissue.
doi:10.3389/fimmu.2022.886468 ↗ PMID 35967326 ↗ PMC9374303 ↗
Study facts
- Organism
- Homo sapiens
- Platform
- Illumina MiSeq
- Age group
- adult
- Disease groups
- —
- Anatomical sites
- —
Data availability
- Analysis code
Strengths & limitations for reuse
Strengths
- Raw reads are advertised
- Feature/OTU tables are advertised
- Taxonomic tables are advertised
- Analysis code is available
- Sample counts are documented
Limitations
- Not documented: participant counts are documented
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.paired_end |
True |
sequenced in paired–end (2 × 300 cycles) Section |
assay.platform |
Illumina MiSeq |
sequenced in paired–end (2 × 300 cycles) on the Illumina MiSeq platform Section |
assay.read_length |
300 |
paired–end (2 × 300 cycles) Section |
assay.sequencing_type |
amplicon_16s |
16S rDNA amplicons (V3-V4 region) Section |
assay.target_region |
V3-V4 |
16S rDNA amplicons (V3-V4 region) Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.age_group |
adult |
We enrolled 28 adult patients Section |
cohort.disease_activity_metadata_available |
True |
comparing first surgery/relapse clinical conditions Section |
cohort.treatment_exposure_documented |
True |
Patients have not been treated with antibiotics, aminosalicylates or immunosuppressants, biological therapy, and steroids for at least 3 weeks before the ICR. Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.analysis_code |
True |
the analysis scripts ... are available at GitHub Section |
data_assets.feature_or_otu_table |
True |
The microbial–related data (raw reads, OTU tables, and taxonomic assignments) are freely available Section |
data_assets.open_access |
True from source |
license: cc by Section |
data_assets.pipeline_or_tool_versions |
True |
raw sequences were processed following the software pipeline MICCA Section |
data_assets.qc_or_negative_controls_reported |
True |
sterile swabs that also underwent sequencing as controls Section |
data_assets.raw_reads |
True |
The microbial–related data (raw reads, OTU tables, and taxonomic assignments) are freely available Section |
data_assets.taxonomic_table |
True |
raw reads, OTU tables, and taxonomic assignments Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.body_site |
ileal mucosa |
matched healthy and inflamed ileal mucosa Section |
specimens.inflamed_status_available |
True |
comparing first surgery/relapse clinical conditions Section |
specimens.number_of_samples |
52 inferred |
Overall design: 26 matched pairs of paraffin-embedded ileal tissue specimens Section |
specimens.sample_type |
mixed |
ileal layers ( mucosa, submucosa and serosa) Section |